On Thursday, July 25, 2019, the Senate Finance Committee voted to approve a wide-ranging drug pricing bill, the Prescription Drug Pricing Reduction Act (PDPRA) of
In a significant reversal of course, on Thursday, July 11, the White House announced that it was withdrawing a proposed rule by the Department of
On Thursday, May 23, Senators Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.), the chair and ranking Democrat of the Health, Education, Labor and Pensions (“HELP”)
On Thursday May 9, 2019 the House Energy and Commerce Committee, Health Subcommittee held a hearing on Lowering Prescription Drug Prices: Deconstructing the Drug Supply
RWC-340B will be scheduling Hill visits for members that are traveling to DC to attend SYNChronicity 2019. RWC-340B Hill visits will take place Tuesday, April
On February 26, 2019, top executives from seven of the largest pharmaceutical companies testified before the Senate Finance Committee attempting to defend the industry’s business
On Monday, December 10, RWC-340B members spent the day on Capitol Hill advocating for the protection of the 340B program for Ryan White grantees and
On October 29, 2018, RWC-340B leaders met with George Sigounas, M.S., Ph.D., the HRSA Administrator, and Beth Nelson, HHS Health Policy Advisor, to advocate to
On Wednesday, October 3, the U.S. Senate approved H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (“SUPPORT”) for Patients and Communities
Republican House Energy and Commerce committee chairmen Greg Walden (R-OR), Michael C. Burgess, M.D. (R-TX), and Gregg Harper (R-MS) sent inquiries to nine pharmacies asking
